Erlotinib Completed Phase 1 Trials for Extrahepatic Bile Duct Cancer / Gallbladder Cancer / Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00565487Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
NCT00925769ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
NCT00243854Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
NCT00885066Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer
NCT00735306Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
NCT00266097Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
NCT00614653Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer